Manifold Bio - About the company
Manifold Bio is a series A company based in United States, founded in 2018 by Gleb Kuznetsov and Shane Lofgren. It operates as a Developer of tissue-targeted therapeutics using in vivo screening and AI design. Manifold Bio has raised $78.2M in funding from Playground Global and Triatomic. The company has 831 active competitors, including 56 funded and 50 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.
Company Details
Developer of tissue-targeted therapeutics using in vivo screening and AI design. The company combines protein design with testing in living systems to sculpt biologics' properties. It has invented molecular tracking technologies to expand in vivo measurement of biologics. The company designs proteins for function and specificity, translating designs into biologics through synthesis and display. It is building a predictive model of living systems to map biomolecule behavior.
- Website
- www.manifold.bio/
- Email ID
- *****@manifold.bio
Key Metrics
Founded Year
2018
Location
Stage
Series A
Total Funding
$78.2M in 3 rounds
Latest Funding Round
Investors
Ranked
4th among 831 active competitors
Employee Count
68 as on Jun 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Manifold Bio
Manifold Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Manifold Biotechnologies, Inc. CIN: 83-4588751 , United States, Active | Dec 31, 2017 | - | - | - |
Sign up to download Manifold Bio's company profile
Manifold Bio's funding and investors
Manifold Bio has raised a total funding of $78.2M over 3 rounds. Its first funding round was on Aug 10, 2020. Manifold Bio has 10 institutional investors.
Here is the list of recent funding rounds of Manifold Bio:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 18, 2024 | 6451384 | Series A | 8126781 | 1601394 | 3498482 | 3772205 |
Jun 13, 2022 | 7641431 | Series A | 6241000 | 9003679 | 9826329 | |
Aug 10, 2020 | 8633487 | Seed | 2245684 | 8460888 |
View details of Manifold Bio's funding rounds and investors
Manifold Bio's founders and board of directors
Founder? Claim ProfileThe founders of Manifold Bio are Gleb Kuznetsov and Shane Lofgren. Gleb Kuznetsov is the CEO of Manifold Bio.
Here are the details of Manifold Bio's key team members:
- Gleb Kuznetsov: Co-Founder & CEO of Manifold Bio. Contact Info: 1 email address
- Shane Lofgren: Co-Founder of Manifold Bio. Contact Info: 1 email address
View details of Manifold Bio's Founder profiles and Board Members
Manifold Bio's employee count trend
Manifold Bio has 68 employees as of Jun 26. Here is Manifold Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Manifold Bio's Competitors and alternates
Top competitors of Manifold Bio include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of Manifold Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alloy Therapeutics 2017, Lexington (United States), Series E | Provider of drug discovery services | $157M | 63/100 | |
2nd | Maiva Pharma 1996, Hosur (India), Late Stage | Manufacturer of sterile injectables | $125M | 61/100 | |
3rd | Simulations Plus 1996, Lancaster (United States), Public | Developer of modeling and simulation software and consulting services provider | - | 60/100 | |
4th | Manifold Bio 2018, United States, Series A | Developer of tissue-targeted therapeutics using in vivo screening and AI design | $78.2M | 54/100 | |
5th | Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus | $42.3M | 53/100 | ||
6th | Biotechnology research company developing biological drugs | $160M | 53/100 | ||
7th | ArcaScience 2018, Paris (France), Seed | Developer of AI models for patient-centric insights in drug development | $7M | 52/100 | |
8th | Viva Biotech 2006, Shanghai (China), Public | Research services focused on drug discovery and development | - | 51/100 | |
9th | Arctoris 2016, Abingdon (United Kingdom), Seed | Provider of automated wet lab biology research and data generation services | $3.93M | 51/100 | |
10th | Superluminal Medicines 2022, Boston (United States), Series A | Generative biological and chemical company focused on drug discovery | $158M | 50/100 |
Looking for more details on Manifold Bio's competitors? Click here to see the top ones
Manifold Bio's Investments and acquisitions
Manifold Bio has a total of 1 investment in UXLINK. Manifold Bio has not made any acquisitions as of now.Reports related to Manifold Bio
Here is the latest report on Manifold Bio's sector:
News related to Manifold Bio
Media has covered Manifold Bio for a total of 4 events in the last 1 year, 2 of them have been about partnerships and 1 about company updates.
•
•
Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics PlatformBusiness Wire•Dec 15, 2025•Manifold Bio
•
•
Modular Yield Layer Cygnus Completes $20 Million Pre-Seed Funding Round, Manifold and Others ParticipatePANews•Feb 19, 2025•Ujala Cygnus, Manifold Bio, OKX, Mirana Toys and 1 other
•
•
Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design PlatformBusiness Wire•Jul 14, 2022•Manifold Bio, Triatomic, Section 32, FPV Ventures and 6 others
•
Are you a Founder ?
FAQs about Manifold Bio
Explore our recently published companies
- Capitalsfb.com - 2018 founded, Unfunded company
- Specule - Delhi based, 2017 founded, Unfunded company
- Tech Hive Technologies - Rawalpindi based, 2017 founded, Unfunded company
- Wise Accelerate - Hanoi based, 2021 founded, Unfunded company
- AblyCon Global - Bengaluru based, 2014 founded, Unfunded company
- Civoya - 2025 founded, Unfunded company